BioCentury
ARTICLE | Company News

Myraqa, Illumina deal

August 11, 2014 7:00 AM UTC

Genomics company Illumina acquired Myraqa, a regulatory and quality consulting firm specializing in in vitro and companion diagnostics. Additionally, Illumina named Myraqa’s founder and CEO Mya Thomae...